Rowan Walrath

An award from ARPA-H is powering Nula Therapeutics Apollo Health Ventures is unveiling a new start-up: Nula Therapeutics , whose funding

Tadaaki Taniguchi is homing in on drug candidates for pancreatic and gastric cancers and genetic diseases

The former surgeon resigned Tuesday after a tumultuous year Key Insights Marty Makary resigned from his position heading the US Food and Drug Administration on Tuesday.

Designing drugs to fight RAS-driven cancers Talented Twelve C&EN's annual Talented 12 issue highlights young scientists who are making the world a better place through chemistry.

The former surgeon resigned Tuesday after a tumultuous year

Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.

The drug company is spending up to $3.8 billion on the acquisitions Eli Lilly and Company is spending up to $3.8 billion to buy three vaccine makers, supercharging its push into the immunology space.

The drug company is spending up to $3.8 billion on the acquisitions

Lundbeck scientists will use Cradle's artificial intelligence software for 2 programs

The start-up is making antivirals and cancer drugs for Big Pharma—and working to treat reproductive problems on its own